Tech Company Financing Transactions

SQZ Biotechnologies Funding Round

SQZ Biotechnologies secured a $4 million funding round on 12/3/2016. Investors included Quark Venture.

Transaction Overview

Announced On
12/3/2016
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Arsenal Yards Blvd.
Watertown, MA 02472
USA
Email Address
Overview
SQZ Biotechnologies (Nasdaq: SQZ). Many promising therapeutic modalities have limited clinical efficacy due to the challenges of delivering molecules into cells. SQZ Biotech seeks to address this fundamental problem by developing its CellSqueeze platform for use in drug discovery and clinical applications.
Profile
SQZ Biotechnologies LinkedIn Company Profile
Social Media
SQZ Biotechnologies Company Twitter Account
Company News
SQZ Biotechnologies News
Facebook
SQZ Biotechnologies on Facebook
YouTube
SQZ Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Armon Sharei
  Armon Sharei LinkedIn Profile  Armon Sharei Twitter Account  Armon Sharei News  Armon Sharei on Facebook
Chief Financial Officer
Teri Loxam
  Teri Loxam LinkedIn Profile  Teri Loxam Twitter Account  Teri Loxam News  Teri Loxam on Facebook
Chief Medical Officer
Oliver Rosen
  Oliver Rosen LinkedIn Profile  Oliver Rosen Twitter Account  Oliver Rosen News  Oliver Rosen on Facebook
Chief Scientific Officer
Howard Bernstein
  Howard Bernstein LinkedIn Profile  Howard Bernstein Twitter Account  Howard Bernstein News  Howard Bernstein on Facebook
Vice President
Katherine Seidl
  Katherine Seidl LinkedIn Profile  Katherine Seidl Twitter Account  Katherine Seidl News  Katherine Seidl on Facebook
Vice President
Marija Tadin-Strapps
  Marija Tadin-Strapps LinkedIn Profile  Marija Tadin-Strapps Twitter Account  Marija Tadin-Strapps News  Marija Tadin-Strapps on Facebook
VP - Finance
Alex Balcom
  Alex Balcom LinkedIn Profile  Alex Balcom Twitter Account  Alex Balcom News  Alex Balcom on Facebook
VP - General Counsel
Larry Knopf
  Larry Knopf LinkedIn Profile  Larry Knopf Twitter Account  Larry Knopf News  Larry Knopf on Facebook
VP - Human Resources
David First
  David First LinkedIn Profile  David First Twitter Account  David First News  David First on Facebook
VP - Regulatory Affairs
Nicole D'Auteuil
  Nicole D'Auteuil LinkedIn Profile  Nicole D'Auteuil Twitter Account  Nicole D'Auteuil News  Nicole D'Auteuil on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/3/2016: Finagraph venture capital transaction
Next: 12/3/2016: Euclises Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary